Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tsunemasa Irie is active.

Publication


Featured researches published by Tsunemasa Irie.


Neuroscience Letters | 1992

Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbils

Satoshi Yamamoto; Toshiki Yoshimine; Toshiaki Fujita; Ryotaro Kuroda; Tsunemasa Irie; Keiji Tsukaguchi-Cho Fujioka; Toru Hayakawa

Very recently, contradictory results were presented as to the effects of exogenous nerve growth factor (NGF) on the hippocampal delayed neuronal necrosis following transient ischemia. In the present study, we administered a large amount of NGF with the atelocollagen mini-pellet system, measured the local NGF contents, and evaluated the effect of this neurotrophic factor on the postischemic hippocampal pyramidal cells in gerbils. We concluded that the exogenous NGF, when given continuously at sufficient concentrations, prevents pyramidal cell damage. The possible cause of discrepancy in previous studies is discussed.


Neuroscience Letters | 1991

Determination of basal acetylcholine release in vivo by rat brain dialysis with a U-shaped cannula: effect of SM-10888, a putative therapeutic drug for Alzheimer's disease

Mann Xu; Yasuharu Nakamura; Toshifumi Yamamoto; Kazuichi Natori; Tsunemasa Irie; Hiroya Utsumi; Takeshi Kato

A U-shaped dialysis cannula was implanted into rat frontal cortex, hippocampus and striatum, and after 1 day for surgical recovery the cannula was perfused with Ringers solution without any acetylcholinesterase (AChE) inhibitor under freely moving conditions. With a highly sensitive assay method for acetylcholine (ACh), the basal ACh content in the dialysates were detectable in those brain regions for several hours. The basal levels in the frontal cortex, hippocampus and striatum were 82 +/- 9, 72 +/- 4, 70 +/- 8 fmol/20 microliters (mean +/- S.E.M.), respectively. When SM-10888, a novel AChE inhibitor and putative therapeutic drug for Alzheimers disease, was injected intraperitoneally, ACh in the dialysate of the cortex increased in a dose-dependent manner. Changes in the levels of hippocampal and striatal ACh release evoked by SM-10888 were similar to, but smaller than, that in the cortex. These data suggest that since the present assay method is able to determine in vivo basal ACh release in the dialysate without any AChE inhibitor, it is possible to study the effect of a novel drug such as SM-10888 in the brain regions.


Archive | 1991

Neurotrophic peptide derivatives

Naoki Tohdoh; Shinichiro Tojo; Shinichi Kojima; Yasuyuki Ueki; Toshio Nishihara; Nobuyuki Fukushima; Tsunemasa Irie; Keiichi Ono; Hideo Agui; Kosei Ojika


Archive | 1990

Sustained-release preparation for administration into brain

Toru Hayakawa; Toshiki Yoshimine; Keiji Fujioka; Yoshihiro Takada; Yoshio Sasaki; Tsunemasa Irie; Nobuyuki Fukushima


Archive | 1992

Instrument for applying pharmaceutical to inside of brain

Toru Hayakawa; Toshiki Yoshimine; Hiromu Aza Gotan Yamamoto; Akira Sato; Tsunemasa Irie; Keiji Tsukaguchi-Cho Fujioka; Yoshihiro Senriyama-Nishi Takada; Yoshio Tsunoe-Cho Sasaki


Japanese Journal of Pharmacology | 1990

Pharmacological and Biochemical Assessment of SM-10888, a Novel Cholinesterase Inhibitor

Kazuichi Natori; Yuko Okazaki; Tsunemasa Irie; Junki Katsube


Japanese Journal of Pharmacology | 1990

Effect of a Novel CNS-Selective Cholinesterase Inhibitor, SM-10888, on Habituation and Passive Avoidance Responses in Mice

Yuko Okazaki; Kazuichi Natori; Tsunemasa Irie; Junki Katsube


Japanese Journal of Pharmacology | 1987

Effect of L-threo-3, 4-Dihydroxyphenylserine (L-DOPS), an Immediate Precursor of Norepinephrine, on the Cerebral Blood Flow in Rats

Etsuro Sato; Tsunemasa Irie; Junki Katsube


Archive | 1983

Conjugated ketone compounds in preventing platelet thrombosis

Atsuyuki Kojima; Tsunemasa Irie; Shuichi Harada; Yoshito Kameno; Junki Katsube; Hisao Yamamoto


Archive | 1993

NEUROTROPHIC PEPTIDES, EXTRACTION FROM MAMMALIAN HIPPOCAMPAL TISSUE AND PHARMACEUTICAL COMPOSITIONS THEREOF

Kosei Ojika; Keiichi Ono; Yoshiharu Ikeda; Yasuyuki Ueki; Tsunemasa Irie; Nobuyuki Fukushima

Collaboration


Dive into the Tsunemasa Irie's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toru Hayakawa

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akira Sato

University of Electro-Communications

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge